Sean Tipton underscores the importance of payer adoption of new treatments and technology which can lead to better patient outcomes.
This is a video synopsis/summary of a Population Health Perspectives® involving Sean Tipton. In the video, Tipton stresses that all parties involved in reproductive care, from device manufacturers to payers and providers, share the goal of healthy patients able to build families. He highlights the importance of payers and providers maintaining open communication, aided by resources like the American Society for Reproductive Medicine (ASRM) that impartially evaluate new techniques’ readiness for widespread use based on aggregated data. Tipton advises that beyond covering infertility treatment, payers must actively work to understand evolving science and technology in partnership with providers and groups like ASRM. He suggests reducing patient demands could boost outcomes, enhance experiences and control costs. For example, fertility medication delivery innovations that decrease patient discomfort and time investments can compel payers to update their formulas. Overall, education and dialogue are central to adapting compensation to advancing practices for optimal efficiency and success. Payers should share information with providers on promising developments to collaboratively determine appropriate payment models centered on patient process streamlining and improved results.
Video synopsis is AIgenerated and reviewed by Managed Healthcare Executive® editorial staff.
Can Lecanemab Succeed Where Aduhelm Failed?
September 28th 2022The announcement of positive phase 3 results for the investigational Alzheimer’s disease drug comes against a backdrop of Aduhelm flaming out. Both drugs are predicated on the theory that Alzheimer’s is caused by beta-amyloid deposits.
Read More